Evaluation of Portal Vein Stenting in Patients With Portal Vein Stenosis and Gastrointestinal Cancers
Prospective Evaluation of Portal Vein (PV) Stenting in Patients With PV Stenosis and Gastrointestinal Malignancies
Sponsor: M.D. Anderson Cancer Center
Listed as NCT04629677, this observational or N/A phase trial focuses on Malignant Digestive System Neoplasm and remains actively recruiting participants. Sponsored by M.D. Anderson Cancer Center, it has been updated 12 times since 2019, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
12 versions recorded-
Feb 2026 — Present [monthly]
Recruiting
-
Aug 2025 — Feb 2026 [monthly]
Recruiting
-
Jun 2025 — Aug 2025 [monthly]
Recruiting
-
Feb 2025 — Jun 2025 [monthly]
Recruiting
-
Sep 2024 — Feb 2025 [monthly]
Recruiting
▶ Show 7 earlier versions
-
Aug 2024 — Sep 2024 [monthly]
Recruiting
-
Jul 2024 — Aug 2024 [monthly]
Recruiting
-
Mar 2024 — Jul 2024 [monthly]
Recruiting
-
Sep 2023 — Mar 2024 [monthly]
Recruiting
Status: Unknown Status → Recruiting
-
Feb 2023 — Sep 2023 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jan 2021 — Feb 2023 [monthly]
Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Recruiting
First recorded
Apr 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- M.D. Anderson Cancer Center
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .